Acute lymphoblastic leukemia following preleukemic syndromes in adults

Leukemia

Volumn 10, Issue 3, 1996, Pages 473-477

  Escudier, S M ^a,b   Albitar, M ^a   Robertson, L E ^a   Andreeff, M ^a   Pierce, S ^a   Kantarjian, H M ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Acute lymphoblastic leukemia; Myelodysplastic syndrome; Preleukemic syndrome

Indexed keywords

AMSACRINE; CYTARABINE; DEXAMETHASONE; DNA NUCLEOTIDYLEXOTRANSFERASE; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; PERIODIC ACID; PREDNISONE; SCHIFF BASE; TUMOR MARKER; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL; BONE MARROW SUPPRESSION; CANCER REGISTRY; CANCER SURVIVAL; CYTOPENIA; DATA BASE; DYSPLASIA; ELECTRON MICROSCOPY; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; PRELEUKEMIA; PRIORITY JOURNAL; PROGNOSIS; T LYMPHOCYTE;

EID: 0029993697     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Mayer RJ, Canellos GP. Primary myelodysplastic syndrome and secondary preleukemia disorders. In: Henderson ES, Lister TA (eds). Leukemia. 5th edn. Saunders: Philadelphia, 1990, pp 613-637.
2. Hussein KK, Salem Z, Bottomley SS, Livingston RB. Acute leukemia in idiopathic sideroblastic anemia: response to combination chemotherapy. Blood 1982; 59: 652-656.
3. San Miguel JF, Hernandez JM, Gonzalez-Sarmiento R, Gonzales M, Sanchez I, Orfao A et al. Acute leukemia after a primary myelodysplastic syndrome: immunophenotypic, genotypic, and clinical characteristics Blood 1991; 78: 768-774.
4. San Miguel JF, Gonzalez M, Canizo MC, Anta JP, Hernandez J, Ortega F et al. The nature of blasts cells in myelodysplastic syndromes evolving to acute leukaemia. Blut 1986; 52: 357-363.
5. Meckenstock G, Fonatsch CH, Heyll A, Schneider EM, Kogler G, Sohngen D et al. T cell receptor γ/δ expressing acute leukemia emerging from sideroblastic anemia: morphological, immunological, and cytogenetic features. Leukemia Res 1992; 16: 379-384.
6. Stark AN, Scott CS, Bhatt B, Roberts BE. Myelodysplastic syndrome coexisting with acute lymphoblastic leukaemia. J Clin Pathol 1986; 39: 728-730.
7. Barton JC, Conrad ME, Parmley RT. Acute lymphoblastic leukemia in idiopathic refractory sideroblastic anemia, evidence for a common lymphoid and myeloid progenitor cell Am J Hematol 1980; 9: 109-115.
8. Berneman ZN, Van Bockstaele D, DeMeyer P, Van der Planken M, Vertessen F, Debock R et al. A myelodysplastic syndrome preceding acute lymphoblastic leukaemia. Br J Haematol 1985; 60: 353-354.
9. Hehlmann R, Zonnchen B, Thiel E, Walther B. Idiopathic refractory sideroachrestic anemia (IRSA) progressing to acute mixed lymphoblastic-myelomonoblastic leukemia. Blut 1983; 46: 11-21.
10. Ascensao JL, Kay NE, Wright JJ, Arthur D, Finkel B, Rydell R et al. Lymphoblastic transformation of myelodysplastic syndrome. Am J Hematol 1986; 22: 431-434.
11. Bonati A, Delia D, Starcich R. Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukaemia with unusual phenotype. Br J Haematol 1986; 64: 487-491.
12. Breatnach F, Chessells JM, Greaves MF. The aplastic presentation of childhood leukaemia: a feature of common-ALL. Br J Haematol 1981; 49: 387-393.
13. Saarinen UM, Wegelius R. Preleukemic syndrome in children. Am J Pediat Hematol/Oncol 1984; 6: 137-145.
14. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199.
15. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985; 103: 620-625.
16. Kantarjian HM, Hirsch-Ginsberg C, Yee G, Huh Y, Freireich EJ, Stass S. Mixed-lineage leukemia revisited: acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy. Blood 1990; 76: 808-813.
17. LeMaistre A, Childs C, Hirsch-Ginsberg I, Reuben J, Cork A, Trujillo J. Heterogeneity in acute undifferentiated leukemia. Hematol Pathol 1988; 2: 79-90.
18. Griffin JD. The use of monoclonal antibodies in the characterization of myeloid leukemias. Hematol Pathol 1987; 1: 81-91.
19. Trujillo JM, Cork A, Ahearn MJ, Youness EL, McCredie KB. Hematologic and cytologic characterization of the 8/21 translocation acute granulocytic leukemia. Blood 1979; 53: 695-706.
20. Keating MJ, Gehan EA, Smith TL, Estey EH, Walters RG, Kantarjian HM et al. A strategy for evaluation of new treatments in untreated patients: application to a clinical trial of AMSA for acute leukemia. J Clin Oncol 1987; 5: 710-721.
21. Kantarjian HM, Walters RS, Keating MJ, Smith TL, O'Brien S, Estey EH et al. Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. J Clin Oncol 1990; 8: 994-1004.
22. Preti HA, O'Brien S, Giralt S, Beran M, Pierce S, Kantarjian HM. Philadelphia chromosome-positive adult acute lymphocytic leukemia characteristics, treatment results, and prognosis. Am J Med 1994; 97: 60-65
23. Kantarjian H, O'Brien S, Beran M, Escudier S, Pierce S, Estey E et al Modified Burkitt regimen for adult acute lymphocytic leukemia (ALL). The hyper-CVAD program. Blood 1993; 82: 10 (abstr.).
24. Sobol RE, Mick R, Royston I, Davey FR, Ellison RR, Newman R et al. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. New Engl J Med 1987; 316: 1111-1117.
25. Rovigatti U, Mirro J, Kitchingman G, Dahl G, Ochs J, Murphy S et al. Heavy chain immunoglobulin gene rearrangement in acute nonlymphocytic leukemia. Blood 1984; 63: 1023-1027.
26. Catovsky D, Matutes E, Buccheri V, Shetty V, Hanslip J, Yoshida N et al. A classification of acute leukemia for the 1990s. Ann Hematol 1991; 62: 16-21.
27. Kurtzberg J, Denning SM, Nycum LM, Singer KH, Haynes B. Immature human thymocytes can be driven to differentiate into nonlymphoid lineages by cytokines from thymic epithelial cells. Proc Natl Acad Sci USA 1989; 86: 7575-7579.
28. Hershfield MS, Kurtzberg J, Harden E, Moore JO, Whang-Peng J, Haynes B. Conversion of a stem cell leukemia from a T lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2′-deoxycoformycin Proc Natl Acad Sci USA 1984; 81: 253-257.
29. - Acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells. Blood 1989; 73: 381-390.
30. Bennett JM, Catovsky D, Daniel M-T et al. Proposal for the recognition of minimally differentiated acute myeloid leukemia (AML-MO). Br J Haematol 1991; 78: 325-329.
31. Preti A, Kantarjian H, Estey E et al. Characteristics and outcome of patients with acute lymphocytic leukemia and myeloperoxidase-positive blasts by electron microscopy. Hematol Pathol 1994; 8: 155-167.